Users online: 2009    [ij] [ij] [ij] 
Email id

Asian Journal of Pharmaceutical Research
Year : 2016, Volume : 6, Issue : 3
First page : ( 159) Last page : ( 169)
Print ISSN : 2231-5683. Online ISSN : 2231-5691.
Article DOI : 10.5958/2231-5691.2016.00023.X

Formulation and Evaluation of Montelukast Sodium Fast Dissolving Tablets

Haque Injamamul1,*, Kumar Ravi2,*, Narayanaswamy VB3, Hoque Mohibul4

1Research Scholar, M. Pharm, (Pharmaceutics), Karavali College of Pharmacy, Mangalore

2Department of Pharmaceutics, Karavali College of Pharmacy, Mangalore

3Department of Pharmacognosy, Karavali College of Pharmacy, Mangalore

4Department of Pharmacology, Karavali College of Pharmacy, Mangalore

*Corresponding Author E-mail: ravikumar300@gmail.com

Online published on 18 October, 2016.


Montelukast sodium is an anti-asthmatic, mainly prevents leukotriene mediated effect associated with asthma. Mouth dissolving tablets of montelukast sodium was prepared by direct compression method using superdisintegrants such as croscarmellose sodium, crospovidone and sodium starch glycolate. Mouth dissolving tablets (MDTs) disintegrates or dissolves rapidly without water within few seconds in the mouth due to the action of superdisintegrants or maximizing pore structure in the formulation. The tablets were prepared using various diluents like MCC, Lactose and superdisintegrants namely Crosscarmellose sodium, Crosspovidone and Sodium starch glycollate in different concentrations. Pre-compression parameters such as angle of repose, bulk density, tapped density, compressibility index, Hausner's ratio were carried out to study the flow properties of powder to achieve uniformity of tablet weight and the values were within permissible limits. The prepared tablets were evaluated for hardness, thickness, weight variation, friability, % drug content, wetting time, water absorption ratio, in vitro disintegration time, in vitro dispersion time and in vitro drug release. The formulation M12 and L12 was found to be the best on the basis of wetting time, in vitro disintegration time and in vitro drug release. Stability studies were carried out at 25°C ± 2°C/60% ± 5% RH and 40°C ± 2°C/75% ± 5% RH for a period of 60 days for the selected formulations. The formulation M12 and L12 containing Crospovidone (8%) as superdisintegrant and microcrystalline cellulose and lactose as diluents was respectively found to be the optimized combination.



Fast dissolving tablets, Superdisintegrants, Diluents, Mouth Dissolving Tablets, Montelukast sodium, Asthama.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
445,146,193 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.